Kodiak Sciences Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-65.6M | $-58.2M | $-56.7M | $-61.5M | $-54.3M | $-57.5M | $-44.1M | $-43.9M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $4.1M | $4.1M | $4.5M | $4.6M | $4.6M | $4.6M | $4.6M | $4.7M |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $11.6M | $12.2M | $13.3M | $14.0M | $15.6M | $15.9M | $8.6M | $14.8M |
| Net Cash from Operating Activities | $-46.2M | $-40.0M | $-39.4M | $-32.9M | $-34.7M | $-29.1M | $-30.1M | $-21.2M |
| Investing Activities | ||||||||
| Capital Expenditures | $352.0K | $942.0K | $43.0K | $60.0K | $133.0K | $270.0K | $124.0K | $180.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-352.0K | $-942.0K | $-43.0K | $-60.0K | $-133.0K | $-270.0K | $-124.0K | $-205.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $3.0M | $619.0K | $177.2M | $813.0K | $120.0K | $124.0K | $404.0K | $0 |
| Net Change in Cash | — | — | — | — | — | — | — | — |
| Free Cash Flow | $-46.6M | $-41.0M | $-39.4M | $-32.9M | $-34.8M | $-29.3M | $-30.2M | $-21.3M |